Product Description
Overall, the global BPH treatment device market was valued at $1.2 billion in 2021. This is expected to increase over the forecast period at a CAGR of 5.2% to reach slightly over $1.7 billion.
The full report suite on the global market for benign prostatic hyperplasia (BPH) treatment devices includes transurethral resection of the prostate (TURP), laser BPH, UroLift® and Rezum® segments. The TURP market is further segmented into monopolar and bipolar electrodes. The laser BPH market includes high-power Holmium equipment and dedicated fiber, as well as thulium equipment and fiber segments. The UroLift® and Rezum® markets are defined by consumables required for each of the procedure.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Procedure Numbers, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL BPH TREATMENT DEVICE MARKET TRENDS
In 2021, the largest segment in the BPH treatment device market was the Laser BPH market, followed by TURP market and UroLift® segment. The Rezum® market generated the smallest portion of the total BPH device market in 2021. Laser BPH market is expected to continue to grow in value as physicians shift towards less invasive techniques and devices.
GLOBAL BPH TREATMENT DEVICE MARKET SHARE INSIGHTS
Overall, within the global urological devices market there are three dominant competitors: Boston Scientific, Teleflex, Olympus.
In 2021, the leading competitor in the BPH treatment device market was Boston Scientific. The company held the dominant leading position in the laser BPH market and a monopolistic position in the Rezūm® market. The company held the second-leading share in North America and was the leading competitor in Western Europe and the rest of the world countries.
GLOBAL BPH TREATMENT DEVICE MARKET SEGMENTATION SUMMARY
- TURP Market
- Laser BPH Fibre Market
- Urolift Market
- Rezūm Market
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
WHY CHOOSE iDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
This MedCore is also found in the full report suite titled Urology Market which contains several other extremities medical device markets.
